Welcome to Nofinity

Coinbase Launches Tokenized Stocks on Base

In this podcast episode, Jesse Pollock, Founder and Lead of Base at Coinbase, introduces Coinbase Tokenized Stocks – a product designed to bring the world's largest asset class, equities, onto the Base blockchain and into the programmable economy.

Key Product Features

• 1:1 Backing: Each tokenized stock represents a real share with a direct claim for the holder. Built in collaboration with Abu Dhabi (ADGM) and Alpaca.
• Dividends & Governance: Dividends are distributed via a rebasing model – the token balance increases automatically. Governance rights are included as well.
• Permissionless & KYC-Free: The tokens are publicly available and freely tradable on Base. US users are only restricted at the interface layer.
• Launch Stocks: Starting with Nvidia, Meta, Apple, and Google, followed by eight more – with plans to scale to thousands over time.

DeFi Integration & Ecosystem

• Aerodrome provides deep liquidity from day one.
• Morpho and AB are building borrowing and lending products around the tokenized stocks.
• This creates a flywheel of lending, borrowing, and yield generation – aiming to grow Base's DeFi TVL from ~$5 billion to over $100 billion.

The Neo-Broker Opportunity

• The product is especially aimed at neo-banks worldwide, enabling them to offer stock trading, credit, and yield products without costly legacy integrations.
• Coinbase envisions Base as the backend for a global financial super app: one API for saving, spending, investing, and borrowing.

Vision & Outlook

• Long-term goal: bring all world currencies on-chain. Base already supports 22–23 non-dollar stablecoins and hosts the largest FX markets on-chain.
• Further building blocks include portfolio lines of credit, seamless on-ramps, and the ability to tokenize stocks directly from traditional brokerages.
• Jesse's key message: "We have all the pieces now – we just have to put them together." The next wave of innovation will be driven by combining AI, programmable assets, and global payment networks.

AI Warren Buffett: A Trading Experiment

This video demonstrates how to build an AI trading bot that mimics Warren Buffett's investment strategy, using the open-source "AI Hedge Fund" project on GitHub. The bot leverages Claude (Fable 5.1) and real-time financial data (e.g., from Financial Datasets) to analyze stocks and execute trades.

Key Steps & Results:

• Stock Analysis: The AI Buffett rated Apple as neutral (60% confidence) and Nvidia cautiously (due to margin concerns). Coca-Cola received the highest confidence (68%).
• Portfolio Construction: With a simulated $100,000 fund, the bot selected 24 stocks from the S&P 500 top 100. Top holding: Microsoft; smallest: IBM. Only 3% cash.
• Backtest (Sept. 2024 to present): The AI Buffett outperformed the S&P 500 with a return of 39.2% vs. 34.8% and a lower max drawdown (5.8% vs. 8%). Best performer: Alphabet (+114%); worst: Accenture (-$2,000).
• Automation: The bot can be connected to an Alpaca paper trading account via API for automatic order execution. Persistent operation on a VPS is supported.

Conclusion:

The simulation suggests an AI model based on Buffett's approach can beat the market — at least in backtesting. However, the creator warns against entrusting real savings to such a bot. The project is intended as an experiment and learning tool.

Introduction

The market has reversed dramatically within a week: Last week AI pause, the Clarity Act, and rate hike fears dominated, but now nobody cares. The video explains why this is called a “Billion Dollar Day” and how the situation in AI and crypto has evolved.

Bitcoin outperforms gold and stocks

Since late June, Bitcoin has risen almost 50% , while gold gained only 9% and the S&P 500 just 4% . This shows extreme relative strength – a sign of risky markets.

Timing risk: Miss the best days and lose everything

Historical examples show that missing Bitcoin’s four strongest days erases nearly all gains. In December 2017, that made the difference between +90% and –23% . The lesson: Don’t try to time the market – even professionals fail.

Market sentiment and macro

The probability of an October rate hike has declined (50/50). Crypto and AI are largely independent of that.

Good news: A billion-dollar day for Bitcoin ETFs

For the first time since the Black Swan day on October 10, 2025, Bitcoin ETFs saw a billion-dollar inflow in a single day. Every billion dollars of inflows corresponds to a 3% price increase for Bitcoin.

MVRV indicator confirms bull market

The 365-day moving average MVRV has turned positive – another signal that the bear market is over. Even the biggest bears admit that now.

Altcoins strong but uneven

Over 7 days: Solana +15% , Zcash +30% , Hype +18% , Ethereum +9% , Bitcoin +11% . Over 30 days: Zcash +94% , Solana +27% , Ethereum +13% , XRP only +7% – unusually weak.

Solana vs. Ethereum: The flip is real

Solana has far surpassed Ethereum in daily transactions (155M vs. 1.69M), active users (5.95M vs. 492K), and DEX volume ($10B vs. $6B). Despite this, Solana’s market cap is only 20% of Ethereum’s – a massive price disconnect. If Ethereum’s price stays flat, Solana could reach $800 .

AI stocks defy the panic

Despite last week’s negative headlines, prices surged: Micron +16% , Broadcom +5.4% , Nvidia +8% , Apple +3% , Meta +12% , Palantir +8% . The reason is continuously upward-revised earnings estimates – driven by massive AI capex.

Tesla and SpaceX: Major events ahead

• Tesla Semi (September 24) – largest order in history: 2.5 million units, 60–70% cost savings vs. diesel.
• Starship orbital launch (September 28) – first attempt with 20–30 new Starlink V3 satellites.
• Roadster unveiling (October 1) – despite speculation, it remains a street car.
• Q3 delivery report – positive for Megapacks and vehicles.

Semiconductors and memory: Exploding demand

• SSD demand to rise 53% in 2027 and another 41% in 2028 – benefiting Micron, SK Hynix, SanDisk.
• Marvell demonstrated a 102.4-terabit switch – a milestone for AI data centers.
• Astera Labs shows falling stock despite rising revenues – a mismatch offering opportunities.

Other news

• CZ invests $100M in Circle (USDC issuer) – a bullish signal; Circle could rise to $130 .
• Tesla and SpaceX use Megapacks for their AI factory power smoothing.

Conclusion

The market is extremely bullish: Bitcoin is up 51.4% in 2.7 months, and according to MVRV, the bull market has only just begun. Despite warnings of overextension, fundamentals remain strong. Missing the best days means losing – so stay invested.

The 2 Amino Acids That Restore Muscle Strength & Burn 78% More Fat

This summary analyzes a study on GlyNAC (Glycine + N-Acetylcysteine) and its effects on mitochondrial health, muscle strength, and fat metabolism in older adults.

The Problem: Energy Crisis in Aging Muscles

• Mitochondrial Dysfunction: Aging muscle cells lose the ability to efficiently burn fatty acids.
• Glutathione Deficiency: Intracellular glutathione, the cell's master antioxidant, is reduced by up to 70% in older adults.
• Root Cause: Two rate-limiting building blocks – glycine and cysteine – are equally depleted with age.

The Solution: GlyNAC (Glycine + N-Acetylcysteine)

• Mechanism: The cell needs both amino acids to produce glutathione. Glycine and NAC provide the missing components.
• Study Design: 24 overweight older adults (61-80 years) received 100 mg/kg glycine + 100 mg/kg NAC daily (approximately 9 g per amino acid for a 90 kg person) for 16 weeks.

The Results: More Strength, More Fat Burning

• Glutathione Increase: +225% in red blood cells, +164% in muscle biopsies – reaching levels of young adults.
• Fat Oxidation: +78% increase.
• Muscle Strength:
  • Gait Speed: +0.21 m/s (matching young adult levels)
  • Grip Strength: +4.4 kg (dominant hand)
  • Chair Rise Test: -6.8 seconds (better leg power)
• No Muscle Gain: Lean mass remained unchanged. Strength gains resulted from improved mitochondrial efficiency.

Additional Positive Effects

• Anti-Inflammatory: Interleukin-6 decreased by 78%, TNF-alpha by 54%, protective interleukin-10 nearly doubled.
• Insulin Resistance: HOMA-IR decreased by 64%.
• Oxidative Stress: DNA damage markers dropped by 73%.
• Blood Pressure: Systolic decreased from 132 to 124 mmHg.

Important Limitations

• High Dosage: The study used very high doses (18 g of amino acids daily). Lower doses have not been tested.
• No Sustained Effect: After stopping GlyNAC, glutathione levels and strength gains returned to baseline.
• Lifespan Extension: The often-cited 24% lifespan increase comes from a mouse study, not human data.

Conclusion

GlyNAC addresses a core cause of age-related strength and energy loss: glutathione deficiency. The results are promising but require medical supervision, especially at high doses and regarding potential drug interactions.

Mission: Dunking a basketball at 49

• A 49-year-old sets the ambitious goal to dunk a basketball – a symbol of youthful athleticism and vitality.
• He trains with a professional coach who works with NBA players and has been at it for nearly 3 months.

Why dunking? – The ultimate biomarker

• Instead of abstract metrics like VO2max (which he previously pushed to elite 18-year-old levels), he now focuses on a visible, relatable target.
• A dunk resonates with people: „The best biomarker I could ever achieve.“

Training approach: Foundation over flash

• Phase 1 (first 2 months): Build a strong physiological base – especially tendon health and stiffness (tendons adapt in 8–12 weeks, muscles in 3–4).
• Phase 2 (from month 3): Add strength (for force production) and later speed (rate of force development).
• Current vertical jump measurement: 23.9 inches (approx. 60.7 cm) – baseline.

Progress & confidence

• After 3 months he feels clear gains and more trust in his body.
• The coach estimates an 80–85% success probability – aided by lean physique, good nutrition and sleep.
• Key: precise execution of drills (e.g., knees over toes in squats, bouncy movements).

Core message

„It‘s not about stopping the negative, it‘s about doing the positive.“ – The journey to a dunk is a statement against age limits.

📉 Three Shocks in One Week – Yet Bitcoin Rallies

• Clarity Act Fails: The first major US crypto regulation bill died in the Senate (49:50, 10 votes short). Coinbase stock fell 8%, Circle ~10%. Bitcoin ignored it.
• Fed Rate Hike: The US Federal Reserve raised rates by 25 basis points (first since 2023). The 10-year Treasury yield spiked above 5%, the Bank of Japan hiked to a 31-year high. Bitcoin still rose.
• AI Sector Weakens: Anthropic's CEO warned about runaway AI progress. Sam Altman and Elon Musk agreed. The semiconductor index dropped over 5%; Nvidia, ASML, SoftBank all fell. Crypto remained unfazed.

💥 Liquidation Cascade: $1 Billion Wiped Out

• 84% of liquidations were shorts ($843M of $1B total).
• In a single hour, over $300M was liquidated, 97% of it shorts.
• Between 126,000 and 135,000 accounts were closed.
• One wallet lost 375 BTC (~$32.5M) in four sequential liquidations over 14 hours.
• Mechanics: Forced buying from short liquidations pushes price higher → triggers next layer of shorts → cascade.

🧠 Why the Bad News Didn't Stick

• Clarity Act irrelevant for markets: A failed bill changes nothing about Bitcoin's functionality (blocks, trades, custody). Crypto grew to over $1 trillion without US regulation.
• Institutions keep buying:
  • Strategy (MicroStrategy) bought 950 BTC for $75M right in the worst news week.
  • US spot Bitcoin ETFs lost $450M on voting day, but regained $433M just three sessions later.
  • Morgan Stanley's Bitcoin ETF logged 20 consecutive days of net inflows.

🔁 Historical Pattern: Bad News = Buying Opportunity

• China ban 2021: >50% of global hashrate went offline → Bitcoin rose from $29K to new ATH in 4 months.
• FTX collapse Nov 2022: Low of $15,400 – the absolute bottom.
• US banking crisis March 2023: Three banks failed, USDC depegged → Bitcoin rallied 40%.
• Inverse: Coinbase IPO April 2021 (peak) and ETF approval January 2024 (price fell from 49K to 38K) – good news marked tops.

✅ Conclusion

Bitcoin is not a market that only rises on good news. The current rally through three parallel shocks shows: A strong holder base and institutional demand drive price independently of politics and macro. Future headlines may be just as grim – but crypto has proven itself through years of uncertainty and hostility. The question: Higher from here, or a bull trap?

Overview

Kaspi.kz (NASDAQ: KSPI) is a super app from Kazakhstan that covers nearly the entire financial and daily life of the country. The stock offers a dividend yield of almost 9 %, a P/E ratio of about 7, and growth of around 17 % – for the analyst, it's hard to find much wrong.

Why Kaspi Stands Out

• Monopoly position: 85 % of payment processing and 70 % market share in consumer commerce in Kazakhstan.
• Government integration: Deep cooperation with the government and central bank – considered “too big to fail.” After a short-seller report (Culper Research), regulators immediately defended the company.
• Super app: Used for healthcare, government services, and banking – practically the entire population depends on it.
• Monopoly with political backing: This only works in Kazakhstan, but there it is a legal money-printing machine.

Growth Driver: Turkey

• Acquisition of Turkish e-commerce leader Hepsiburada for $1.1 billion.
• Acquisition of a banking license (Rabobank license) and planned capital injection of $300 million.
• Expansion of a “Buy Now, Pay Later” business and integration of fintech solutions into the Turkish platform.
• If Turkish profitability even approaches Kazakh levels, this could become a major winner.

Financial Highlights

• Net income is growing, stable net margin of around 27 %.
• E-commerce growth and payment business are strong thanks to the monopoly position.
• Non-performing loans (NPL): About 6–7 % and slightly rising – worth watching, but cushioned by high interest rates (15 % central bank rate).
• Balance sheet: $15 billion in customer loans, $17 billion in customer deposits – typical bank risks, but with fintech margins.

Risks

• Kazakhstan risk: Political connections, corruption allegations, possible rumors about bank stability.
• Dependence on the state: If political support changes, the business model would be in danger.
• Currency risk: Tenge fluctuations, but growth remains strong when measured in dollars.
• Bank risk: As a financial company, always vulnerable to loss of confidence and potential bank runs.

Conclusion

• P/E of 8 with 15 % growth and an 8–9 % dividend yield provide a margin of safety.
• Tencent as an investor and the “Silk Belt and Road” connection to China are additional strategic pluses.
• Founders own 66 % of the capital – without them the construct would not work, which creates resilience.
• The analyst is considering adding the stock to his diversified portfolio, although he considers the environment risky. “Hard to find much wrong” – but it remains an engaged emerging-market investment.